Trade

with

GlaxoSmithKline PLC
(NYSE: GSK)
AdChoices
43.63
+0.02
+0.05%
Pre-Market :
42.88
-0.75
-1.72%

Open

43.09

Previous Close

43.61

Volume (Avg)

10.02M (5.28M)

Day's Range

43.03-43.74

52Wk Range

41.91-56.73

Market Cap.

104.90B

Dividend Rate (Yield )

2.59 (6.08%)

Beta

0.62

Shares Outstanding

2.40B

P/E Ratio (EPS)

13.99 (3.13)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Major
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 42.77B

    • Net Income

    • 8.77B

    • Market Cap.

    • 104.90B

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 19.32

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 0.62

    • Forward P/E

    • 23.31

    • Price/Sales

    • 2.69

    • Price/Book Value

    • 10.60

    • Price/Cash flow

    • 11.16

      • EBITDA

      • 14.18B

      • Return on Capital %

      • 11.75

      • Return on Equity %

      • 75.85

      • Return on Assets %

      • 11.75

      • Book Value/Share

      • 6.65

      • Shares Outstanding

      • 2.40B

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.65 (8/6/2014)

      • Dividend Declaration Date

      • 7/23/2014

      Analyst Recommendation
      10/20/2014
      Outperform
        • 1 Year Price Target

        • 25.71

        • Credit Rating

        • A+

        • Analysts

        • 8

        • EPS Estimate

        • 1.27

        • Cashflow Estimate

        • 2.16

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -16.00

          • 0.89

          • Net Income

            YTD/YTD (last year)

          • 19.10

          • 7.80

          • Net Income

            Q/Q (last year)

          • -37.40

          • 4.50

          • Sales (Revenue)

            5-Year Annual Average

          • 1.71

          • 6.10

          • Net Income

            5-Year Annual Average

          • 2.90

          • 3.73

          • Dividends

            5-Year Annual Average

          • 6.58

          • 2.17

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 67.05

            • 69.92

            • Pre-Tax Margin

            • 23.74

            • 21.84

            • Net Profit Margin

            • 19.32

            • 18.37

            • Average Gross Margin

              5-Year Annual Average

            • 71.60

            • 71.90

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 23.50

            • 21.92

            • Average Net Profit Margin

              5-Year Annual Average

            • 16.40

            • 903.40B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 2.37

              • 0.32

              • Current Ratio

              • 1.11

              • 1.92

              • Quick Ratio

              • 0.68

              • 1.31

              • Interest Coverage

              • 9.52

              • 17.64

              • Leverage Ratio

              • 6.35

              • 2.03

              • Book Value/Share

              • 4.10

              • 14.72

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 13.99

                • 21.88

                • P/E Ratio 5-Year High

                • 18.17

                • 193.96

                • P/E Ratio 5-Year Low

                • 10.30

                • 87.26

                • Price/Sales Ratio

                • 2.70

                • 3.70

                • Price/Book Value

                • 10.65

                • 3.69

                • Price/Cash Flow Ratio

                • 11.16

                • 13.85

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 75.85

                    (58.40)

                  • 17.42

                    (18.66)

                  • Return on Assets %

                    (5-Year Average)

                  • 11.75

                    (10.80)

                  • 8.45

                    (8.77)

                  • Return on Capital %

                    (5-Year Average)

                  • 21.84

                    (20.90)

                  • 12.41

                    (13.18)

                  • Income/Employee

                  • 47.78k

                  • 90.07k

                  • Inventory Turnover

                  • 1.96

                  • 2.46

                  • Asset Turnover

                  • 0.61

                  • 0.46

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  11.34B
                  Operating Margin
                  26.52
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  11.16
                  Ownership

                  Institutional Ownership

                  11.82%

                  Top 10 Institutions

                  5.93%

                  Mutual Fund Ownership

                  3.44%

                  Float

                  -

                  5% / Insider Ownership

                  -

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dodge & Cox Stock Fund

                  •  

                    16,329,300

                  • -33.17

                  • 0.68

                  • Dodge & Cox International Stock Fund

                  •  

                    11,268,249

                  • -43.24

                  • 0.47

                  • AllianzGI NFJ Dividend Value Fund

                  •  

                    4,076,200

                  • 0.00

                  • 0.17

                  • T. Rowe Price International Grth & Inc

                  •  

                    3,367,772

                  • 0.00

                  • 0.14

                  • Vanguard PrimeCap Fund

                  •  

                    3,255,400

                  • -32.52

                  • 0.14

                  • Dodge & Cox Balanced Fund

                  •  

                    3,084,500

                  • -35.21

                  • 0.13

                  • T. Rowe Price Overseas Stock Fund

                  •  

                    3,018,713

                  • 0.73

                  • 0.13

                  • Fidelity® Series Growth & Income Fund

                  •  

                    1,982,900

                  • 8.40

                  • 0.08

                  • American Beacon Large Cap Value Fund

                  •  

                    1,669,100

                  • 86.20

                  • 0.07

                  • Fidelity® Growth & Income Portfolio

                  •  

                    1,606,822

                  • 7.09

                  • 0.07

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Dodge & Cox

                  •  

                    60,226,050

                  • -0.27%

                  • 2.51

                  • Royal Bank Of Canada

                  •  

                    14,012,351

                  • +0.06%

                  • 0.58

                  • Fisher Asset Management, LLC

                  •  

                    11,488,594

                  • +1.08%

                  • 0.48

                  • State Street Corp

                  •  

                    10,809,995

                  • -0.66%

                  • 0.45

                  • T. Rowe Price Associates, Inc.

                  •  

                    9,039,831

                  • +0.47%

                  • 0.38

                  • Merrill Lynch & Co Inc

                  •  

                    9,017,749

                  • +9.54%

                  • 0.38

                  • Renaissance Technologies Corp

                  •  

                    8,869,400

                  • +26.53%

                  • 0.37

                  • BNY Mellon Wealth Management

                  •  

                    6,383,675

                  • -1.21%

                  • 0.27

                  • Fidelity Management and Research Company

                  •  

                    6,210,354

                  • -2.29%

                  • 0.26

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Major

                  Type

                  Slow Growth

                  Style

                  Large Value

                  GlaxoSmithKline PLC incorporated in United Kingdom. The Company creates, discoveres, develops, manufactures and markets pharmaceutical products including vaccines, over-the-counter (OTC) medicines and health-related consumer products...more. The Company's principal pharmaceutical products include medicines in the following therapeutic areas: respiratory, anti-virals, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterials, oncology and emesis, dermatology, rare diseases, immuno-inflammation, vaccines and HIV. The Company is a science-led global healthcare company that researches and develops a broad range of innovative products in three primary areas of pharmaceuticals, vaccines and consumer healthcare. Its Pharmaceuticals business develops and makes medicines to treat a broad ran...morege of acute and chronic diseases. Its portfolio is made up of both patent-protected and off patent medicines. Its products include treatment for Infectious Diseases, Cancer, Epilepsy, Heart Disease, Asthma and Chronic obstructive pulmonary disease, and HIV/AIDS. Its Vaccine business has approximately 900 million doses distributed to 170 countries in 2012. It produces paediatric and adult vaccines to prevent a range of infectious diseases including: Hepatitis A and B, Diphtheria, Tetanus and Whooping cough, Measles, Mumps and Rubella, Polio, Typhoid, Influenza, Bacterial Meningitis. The consumer healthcare business, markets consumer health products based on scientific innovation. Its products main categories are: Oral care, Nutritional, Total wellness, and Skin health. Its barands include Sensodyne, Panadol and Horlicks. Its drinks brands are Lucozade and Ribena. The Oral Care brands, alli and Abreva.lessless

                  Key People

                  Sir Andrew Witty

                  Director/CEO

                  Sir Christopher Charles Gent

                  Chairman of the Board/Director

                  Dr. Moncef M Slaoui PhD

                  Chairman of the Board, Divisional/Director

                  Mr. Simon Dingemans

                  CFO/Director

                  Ms. Judy C. Lewent

                  Director

                  • GlaxoSmithKline PLC

                  • 980 Great West Road

                  • Brentford, Middlesex TW8 9GS

                  • GBR.Map

                  • Phone: +44 2080475000

                  • Fax: +44 2080477807

                  • gsk.com

                  Incorporated

                  1999

                  Employees

                  99,451

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: